Connor, Clark & Lunn Investment Management (CC&L)’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$3.23M Buy
2024
Q4
Sell
2024
Q3
$579K Buy
2024
Q2
$452K Buy
2024
Q1
Sell
2023
Q4
$272K Buy
2022
Q4
Sell
2022
Q3
$727K Buy